Terms: = Skin cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
121 results:
1. Two congenital cases of pigmented epithelioid melanocytoma with unique clinical and genetic features.
Zaaroura H; Cyrenne B; Somers GR; Wong KW; Davidge KM; Propst EJ; Kulkarni AV; Lo W; Villani A; Lara-Corrales I; Levy R
Dermatol Online J; 2023 Oct; 29(5):. PubMed ID: 38478639
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.
Fernández-Guarino M; Ortiz P; Gallardo F; Llamas-Velasco M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396877
[TBL] [Abstract] [Full Text] [Related]
3. Extra-ocular sebaceous carcinoma - A rare case report.
Sindhura M; Santosh T; Kumar JR; Shankaralingappa A; Pannerselvam NK; Balakrishna P
Indian J Pathol Microbiol; 2024; 67(1):169-171. PubMed ID: 38358213
[TBL] [Abstract] [Full Text] [Related]
4. METASTATIC NODULAR MELANOMA DEVELOPING ON NEVUS SPILUS DURING INTAKE OF BETA BLOCKERS (BISOPROLOL/NEBIVOLOL) AND ACE INHIBITORS (PERINDOPRIL). POTENTIAL LINKS TО THE DRUG RELATED NITROSOGENESIS/CARCINOGENESIS, DUNNING-KRUGER EFFECT AND GENETIC WEAPONS OF THE NEW GENERATION.
Tchernev G
Georgian Med News; 2023 Oct; (343):172-178. PubMed ID: 38096536
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
[TBL] [Abstract] [Full Text] [Related]
6. Intraoral sebaceous carcinoma: A rare presentation on the tongue and review of the literature.
Silva Cunha JL; Paes de Almeida O; de Carvalho MGF; Dantas Soares C
Oral Oncol; 2024 Jan; 148():106647. PubMed ID: 38006687
[TBL] [Abstract] [Full Text] [Related]
7. NITROSAMINES IN COMMONLY PRESCRIBED ANTIHYPERTENSIVES AND THE (UN)CONTROLLED DRUG-INDUCED skin cancer: SIMULTANEOUS DEVELOPMENT OF CUTANEOUS MELANOMA AND MULTIPLE BCC AFTER CONCOMITANT ADMINISTRATION OF BISOPROLOL AND FUROSEMIDE.
Tchernev G
Georgian Med News; 2023 Sep; (342):149-151. PubMed ID: 37991971
[TBL] [Abstract] [Full Text] [Related]
8. Recommendations for risk minimization when using Janus kinase inhibitors for the treatment of chronic inflammatory skin diseases.
Wohlrab J; Kegel T; Große R; Eichner A
J Dtsch Dermatol Ges; 2023 Aug; 21(8):845-851. PubMed ID: 37345890
[TBL] [Abstract] [Full Text] [Related]
9. Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of cancer.
Reale A; Krutzke L; Cadamuro M; Vitiello A; von Einem J; Kochanek S; Palù G; Parolin C; Calistri A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298206
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of 20% mannitol and 3% hypertonic saline for intraoperative brain relaxation during supratentorial brain tumour craniotomy in patients with a midline shift.
Hernández-Palazón J; Doménech-Asensi P; Fuentes-García D; Burguillos-López S; Piqueras-Pérez C; García-Palenciano C
Neurocirugia (Astur : Engl Ed); 2023; 34(6):273-282. PubMed ID: 36931929
[TBL] [Abstract] [Full Text] [Related]
11. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
[TBL] [Abstract] [Full Text] [Related]
12. Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K; Sabat-Pospiech D; Barlow S; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2022 Dec; 11(12):13. PubMed ID: 36576731
[TBL] [Abstract] [Full Text] [Related]
13. Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Schumann K; Mauch C; Klespe KC; Loquai C; Nikfarjam U; Schlaak M; Akçetin L; Kölblinger P; Hoellwerth M; Meissner M; Mengi G; Braun AD; Mengoni M; Dummer R; Mangana J; Sindrilaru MA; Radmann D; Hafner C; Freund J; Rappersberger K; Weihsengruber F; Meiss F; Reinhardt L; Meier F; Rainer B; Richtig E; Ressler JM; Höller C; Eigentler T; Amaral T; Peitsch WK; Hillen U; Harth W; Ziller F; Schatton K; Gambichler T; Susok L; Maul LV; Läubli H; Debus D; Weishaupt C; Börger S; Sievers K; Haferkamp S; Zenderowski V; Nguyen VA; Wanner M; Gutzmer R; Terheyden P; Kähler K; Emmert S; Thiem A; Sachse M; Gercken-Riedel S; Kaune KM; Thoms KM; Heinzerling L; Heppt MV; Tratzmiller S; Hoetzenecker W; Öllinger A; Steiner A; Peinhaupt T; Podda M; Schmid S; Wollina U; Biedermann T; Posch C
J Eur Acad Dermatol Venereol; 2023 May; 37(5):894-906. PubMed ID: 36433688
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue.
Roseboom IC; Thijssen B; Rosing H; Alves F; Younis BM; Musa AM; Beijnen JH; Dorlo TPC
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123494. PubMed ID: 36219923
[TBL] [Abstract] [Full Text] [Related]
15. Readability of online patient education materials for Merkel cell carcinoma.
Zhang Y; Nguyen CC; Bilimoria KY; Merkow RP
Arch Dermatol Res; 2023 Apr; 315(3):629-632. PubMed ID: 35976406
[TBL] [Abstract] [Full Text] [Related]
16. Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in cancer in Patients with Advanced Non-small Cell Lung cancer or Melanoma: A Meta-analysis.
Digkas E; Tabiim AJ; Smith D; Valachis A
Target Oncol; 2022 Sep; 17(5):507-515. PubMed ID: 35913645
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue.
Roseboom IC; Thijssen B; Rosing H; Alves F; Sundar S; Beijnen JH; Dorlo TPC
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Aug; 1206():123354. PubMed ID: 35810536
[TBL] [Abstract] [Full Text] [Related]
18. Addiction of Merkel cell carcinoma to muc1-C identifies a potential new target for treatment.
Morimoto Y; Fushimi A; Yamashita N; Hagiwara M; Bhattacharya A; Cheng J; Frost TC; Ahmad R; Daimon T; Huang L; Hata T; Takahashi H; Yamamoto M; Suzuki Y; DeCaprio JA; Kufe D
Oncogene; 2022 Jul; 41(27):3511-3523. PubMed ID: 35688945
[TBL] [Abstract] [Full Text] [Related]
19. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
[TBL] [Abstract] [Full Text] [Related]
20. A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.
Chan PY; Phillips MM; Ellis S; Johnston A; Feng X; Arora A; Hay G; Cohen VML; Sagoo MS; Bomalaski JS; Sheaff MT; Szlosarek PW
Pigment Cell Melanoma Res; 2022 Jul; 35(4):461-470. PubMed ID: 35466524
[TBL] [Abstract] [Full Text] [Related]
[Next]
